Menu

ABVC BioPharma, Inc. ABVC

Full chart Compare
Set alert

Price alert · ABVC

All alert types
0.97 USD 0.00 (-0.25%)

At closeNov 6, 2026, 4:01 PM EST

0.98 +0.01 +1.35%

After hours · Nov 6, 4:01 PM ET

0.9501 Day range 0.98
0.711 52-week range 2.99
YTD
-54.52%
1 year
-65.89%

Revenue & Expenses

Income Tax Benefit → Expenses: $110.54KExpenses → Selling, General & Admin: $5.03MExpenses → Research & Development: $179.27KExpenses → Other Expenses: $308.18KGross Profit → Expenses: $508.83KRevenue → Gross Profit: $508.83KRevenue → Cost of Revenue: $763Net Loss → Expenses: $4.90MIncome Tax Benefit$110.54KGross Profit$508.83KNet Loss$4.90MCost of Revenue$763Expenses$5.52MSelling, General & Admin$5.03MResearch & Development$179.27KOther Expenses$308.18KRevenue$509.59K

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

ABVC annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
7.15M5.21M6.62M15.80M12.06M
121.08K179.27K1.06M2.69M1.00M
2.89M2.26M5.37M6.07M5.75M
-7.15M-4.71M-6.77M-15.11M-11.71M
415.89K825.90K1.31M293.97K227.21K
24.15K-110.54K256.01K797.78K825.02K
-7.91M-4.90M-7.79M-16.42M-12.84M
-7.91M-4.90M-7.79M-16.42M-12.84M
-7.91M-4.90M-7.79M-16.42M-12.84M
-8.38M-5.26M-8.28M-16.31M-12.04M
-468.40K-356.16K-492.79K110.86K802.96K
-0.39-0.42-1.80-5.19-5.10
-0.39-0.42-1.80-5.19-5.10
-0.39-0.42-1.80-5.19-5.10
-7.47M-4.19M-6.22M-15.33M-11.79M
-7.47M-4.19M-6.22M-15.33M-11.79M
20.11M11.67M4.34M3.17M2.51M
20.11M11.67M4.34M3.17M2.51M